4//SEC Filing
Honore Tage 4
Accession 0000950170-24-063022
CIK 0001347178other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:55 PM ET
Size
7.1 KB
Accession
0000950170-24-063022
Insider Transaction Report
Form 4
Honore Tage
Director
Transactions
- Award
Common Stock
2024-05-17+20,529→ 64,244 total - Award
Stock Option (right to buy)
2024-05-17+37,578→ 37,578 totalExercise: $5.48Exp: 2034-05-16→ Common Stock (37,578 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
- [F2]This option vests and becomes exercisable with respect to 100% of the option shares on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001967946
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:55 PM ET
- Size
- 7.1 KB